Covid-19: Hydroxychloroquine does not benefit hospitalised patients, UK trial finds
Hydroxychloroquine does not reduce the risk of dying or improve other outcomes in hospitalised patients treated for covid-19, preliminary results from the UK RECOVERY trial have shown.Announcing the…
